Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Stock analysts at HC Wainwright cut their FY2026 earnings estimates for shares of Arrowhead Pharmaceuticals in a research note issued to investors on Thursday, August 6th. HC Wainwright analyst P. Trucchio now expects that the biotechnology company will earn ($3.33) per share for the year, down from […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Zacks Research Analysts Increase Earnings Estimates for ARWR | 0 | 11.84 | 10-08-2026 |
| 2 | FY2027 Earnings Forecast for Ardelyx Issued By HC Wainwright | 0 | 13.4 | 10-08-2026 |
| 3 | What is HC Wainwright’s Estimate for PTGX FY2026 Earnings? | 0 | 13.4 | 10-08-2026 |
| 4 | Truist Financial Cuts Arrow Electronics (NYSE:ARW) Price Target to $250.00 | 0 | 10.8 | 10-08-2026 |
| 5 | Energy Fuels FY2026 EPS Estimate Reduced by HC Wainwright | 0 | 13.4 | 10-08-2026 |
| 6 | Analysts Issue Forecasts for Energy Fuels FY2026 Earnings | 0 | 13.04 | 10-08-2026 |
| 7 | Research Analysts Offer Predictions for CMPX Q3 Earnings | 0 | 11.48 | 10-08-2026 |
| 8 | HC Wainwright Has Optimistic Outlook of TNYA FY2026 Earnings | 0 | 11.9 | 10-08-2026 |
| 9 | HC Wainwright Issues Pessimistic Outlook for SABS Earnings | 0 | 12.58 | 10-08-2026 |
| 10 | HC Wainwright Estimates McEwen’s FY2026 Earnings (NYSE:MUX) | 0 | 12.67 | 10-08-2026 |